Crossmark

Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab

Published Online: 2022-09-01

Published Print: 2022-12

Authors

Craner, Matthew

Al Malik, Yaser

Babtain, Fawzi A.

Alshamrani, Foziah

Alkhawajah, Mona M.

Alfugham, Nora

Al-Yafeai, Rumaiza H.

Aljarallah, Salman

Makkawi, Seraj

Qureshi, Shireen

Ziehn, Marina

Wahba, Hazem
Funding

Funding for this research was provided by:

Novartis
License Information

Text and Data Mining valid from 2022-09-01

Version of Record valid from 2022-09-01
More Information

Article History

Received: 6 July 2022

Accepted: 17 August 2022

First Online: 1 September 2022

Document is current